Skip to content

Impact of oral Melatonin on sedation and recovery with intranasal Dexmedetomidine in children undergoing MRI.

Evaluation of the effectiveness of oral Melatonin as a premedication to intranasal Dexmedetomidine for sedation in paediatric patients undergoing magnetic resonance imaging - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102691
Enrollment
80
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

Intervention1: oral Melatonin: Oral melatonin syrup (0.25 mg per kg up to a maximum of 3 mg for children more than or equal to 15 kg, or up to a maximum of 6 mg for children more than or equal to 15

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged 1 to 10 years of either sex 2.American Society of Anaesthesiologists, physical status 1 to 3 3.Scheduled for elective, non contrast brain MRI

Exclusion criteria

Exclusion criteria: 1.Refusal of consent by parents/guardians Recent 2.upper respiratory tract infection (less than 2 weeks) 3.Inadequate fasting status (solids less than 6h, clear fluids less than 2h) 4.Nasal deformity/obstruction (e.g. Choanal atresia) 5.Anticipated difficult airway 6.Significant systemic disease or contraindication to study drugs

Design outcomes

Primary

MeasureTime frame
Time to onset of adequate sedation which will be measured as the interval (in minutes) from intranasal dexmedetomidine administration to achievement of a University of Michigan Sedation Scale (UMSS) score more than or equal to 3 in both groups.Timepoint: Time after administration of Intranasal Dexmedetomidine in minutes at which University of Michigan Sedation Scale score more than or equal to 3 achieved.

Secondary

MeasureTime frame
Compliance during IV cannulation, assessed using the Children s Emotional Manifestation Scale (CEMS) in both groups.Timepoint: After administration of oral Melatonin when the UMSS Score of more than or equal to 3 will be achieved.;Success rate of sedation, proportion of children achieving successful sedation, defined as completion of MRI without intravenous (IV) rescue sedation and maintaining a UMSS of more than or equal to 3 throughout imaging, compared between the two groups.Timepoint: Immediately after completion of MRI;Requirement for rescue sedation, number of patients requiring IV rescue sedation and the total cumulative dose ( g/kg) of rescue sedation administered during MRI, compared between the two groups.Timepoint: During MRI;Movement episodes during MRI via the Movement ScoreTimepoint: During MRI;Monitoring of parameters including HR, NIBP, Oxygen Saturation(baseline,every 5 min)Timepoint: During MRI;Parental satisfaction will be assessed post-procedure using a 5-point Likert Scale in both groups.Timepoint: At the time of discharge;Time to discharge measured as the interval (in minutes) from completion of MRI to achievement of a Modified Aldrete Score more than or equal to 9, compared between the two groups.Timepoint: After completion of MRI;Following Adverse events will be noted: hypotension, bradycardia, desaturation, airway obstruction, prolonged sedation, Emergence agitation/delirium via the Paediatric Anaesthesia Emergence Delirium Scale (PAED) scaleTimepoint: After administration of Oral melatonin, During MRI, After the completion of MRI;Total Sedation Time from UMSS more than or equal to 3 to Modified Aldrete Score more than or equal to 9Timepoint: After administration of the oral Melatonin to before the discharge of the patient;Total hospital stay post-MRITimepoint: After Completion of MRI

Countries

India

Contacts

Public ContactDr Sanjeev Palta

Government Medical College and Hospital, Chandigarh

richajayant@rediffmail.com9646121513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026